INFUSIONE SISTEMICA CONTINUA SINUSOIDALE DI FUDR NEL CARCINOMA COLORETTALE AVANZATO. ESPERIENZA PRELIMINARE

Translated title of the contribution: Continuous sinusoidal systemic Fudr infusion in advanced colorectal cancer. Preliminary experience

D. Civalleri, M. Cavallini, D. T. Danesi, F. Decian, M. Depaoli, N. Balletto

Research output: Contribution to journalArticlepeer-review

Abstract

Continuous sinusoidal systemic Fudr infusion in advanced colorectal cancer. Preliminary experience. Sinusoidal circadian continuous infusion with a maximal flow rate in the afternoon (3-9 pm) reduces Fudr toxicity. In order to estimate if the reported lower toxicity is merely due to the quasi-intermittence of the daily dose or to the circadian rhythm of infusion. Ten patients with widespread cancer (9 colorectal and 1 renal) underwent sinusoidal continuous iv Fudr infusion with the peak level in antiphase (ie 68% of the dose from 3 to 9 am) as compared with the Romeling shape. An initial dose of 0.15 mg/kg/d for 14 days monthly has been given, escalating it every cycle by 0.025 mg/kg/d increments until toxicity. Mean (±SD) number of cycles has been 4.1 ± 2.1 (range 2-8), maximal dose given has been 0.2 mg/kg/die in 5 patients and mean dose intensity of 0.570 ± 0.04. Gastrointestinal toxicity consisted of nausea/vomiting WHO grade 1 in one patient and diarrhoea grade 1 in two, grade 2 and 3 in one and one case. Toxicity and dose intensity of both sinusoidal infusion seem to be similar and allow higher dose of Fudr than continuous constant infusion. Some other studies have to be done to include pharmacokinetics evaluation in order to estimate chronobiologic implication in continuous Fudr infusion.

Translated title of the contributionContinuous sinusoidal systemic Fudr infusion in advanced colorectal cancer. Preliminary experience
Original languageItalian
Pages (from-to)853-858
Number of pages6
JournalMinerva Chirurgica
Volume47
Issue number9
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Continuous sinusoidal systemic Fudr infusion in advanced colorectal cancer. Preliminary experience'. Together they form a unique fingerprint.

Cite this